Carbapenem-Resistant Pseudomonas aeruginosa Spondylodiscitis Treated with Ceftazidime-Avibactam: A Case Report with Literature Review

References

• Nickerson EK, Sinha R. Vertebral osteomyelitis in adults: an update. Br Med Bull. 2016;117(1):121–138. doi:10.1093/bmb/ldw003
   PubMed Web of Science ®Google Scholar
• Bernard L, Dinh A, Ghout I, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385(9971):875–882. doi:10.1016/S0140-6736(14)61233-2
   PubMed Web of Science ®Google Scholar
• Da LY, Wong CB, Tsai TT, et al. Appropriate duration of post-surgical intravenous antibiotic therapy for pyogenic spondylodiscitis. BMC Infect Dis. 2018;18(1):468–476. doi:10.1186/s12879-018-3377-1
   PubMedGoogle Scholar
• Waheed G, Soliman MAR, Ali AM, Aly MH. Spontaneous spondylodiscitis: review, incidence, management, and clinical outcome in 44 patients. Neurosurg Focus. 2019;46(1):E10. doi:10.3171/2018.10.FOCUS18463
   PubMed Web of Science ®Google Scholar
• Fantoni M, Trecarichi EM, Rossi B, et al. Epidemiological and clinical features of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012;16(Suppl. 2):2–7.
   PubMedGoogle Scholar
• Chong BSW, Brereton CJ, Gordon A, Davis JS. Epidemiology, microbiological diagnosis, and clinical outcomes in pyogenic vertebral osteomyelitis: a 10-year retrospective cohort study. Open Forum Infect Dis. 2018;5(3):ofy037. doi:10.1093/ofid/ofy037
   PubMed Web of Science ®Google Scholar
• Issa K, Diebo BG, Faloon M, et al. The epidemiology of vertebral osteomyelitis in the United States from 1998 to 2013. Clin Spine Surg. 2018;31(2):E102–E108. doi:10.1097/BSD.0000000000000597
   PubMed Web of Science ®Google Scholar
• Kehrer M, Pedersen C, Jensen TG, Lassen AT. Increasing incidence of pyogenic spondylodiscitis: a 14-year population-based study. J Infect. 2014;68(4):313–320. doi:10.1016/j.jinf.2013.11.011
   PubMed Web of Science ®Google Scholar
• Akiyama T, Chikuda H, Yasunaga H, Horiguchi H, Fushimi K, Saita K. Incidence and risk factors for mortality of vertebral osteomyelitis: a retrospective analysis using the Japanese diagnosis procedure combination database. BMJ Open. 2013;3(3):e002412. doi:10.1136/bmjopen-2012-002412
   PubMed Web of Science ®Google Scholar
• Costa J, de Andrade N, Arcangelo J, Pedrosa C, Figueira P. Espondilodiscite piogênica em adultos-diagnóstico e tratamento [Pyogenic spondylodiscitis in adults-diagnosis and treatment]. Rev Port Ortop e Traumatol. 2015;23(3):225–235.
   Google Scholar
• Graña D, Gutiérrez MI, Torres D, Perendones M, Dufrechou C. Espondilodiscitis bacteriana inespecífica: una afección con incidencia creciente [Non Specific Bacterial Spondylodiscitis: an increasingly frequent condition]. Arch Med Interna. 2014;36(2):55–59.
   Google Scholar
• Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) Clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015;61(6):e26–e46. doi:10.1093/cid/civ482
   PubMed Web of Science ®Google Scholar
• Raghavan M, Lazzeri E, Palestro CJ. Imaging of spondylodiscitis. Semin Nucl Med. 2017;48(2):131–147. doi:10.1053/j.semnuclmed.2017.11.001
   Web of Science ®Google Scholar
• Lener S, Hartmann S, Barbagallo GMV, Certo F, Thomé C, Tschugg A. Management of spinal infection: a review of the literature. Acta Neurochir. 2018;160(3):487–496. doi:10.1007/s00701-018-3467-2
   PubMed Web of Science ®Google Scholar
• Boody BS, Tarazona DA, Vaccaro AR. Evaluation and management of pyogenic and tubercular spine infections. Curr Rev Musculoskelet Med. 2018;11(4):643–652. doi:10.1007/s12178-018-9523-y
   PubMed Web of Science ®Google Scholar
• Park K-H, Cho OH, Lee JH, et al. Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence. Clin Infect Dis. 2016;62(10):1262–1269. doi:10.1093/cid/ciw098
   PubMed Web of Science ®Google Scholar
• Rempenault C, Pagis V, Noussair L, et al. Treatment of bone and joint infections by ceftazidime/avibactam and ceftolozone/tazobactam: a cohort study. J Glob Antimicrob Resist. 2021;25:282–286. doi:10.1016/j.jgar.2021.04.003
   PubMed Web of Science ®Google Scholar
• Cani E, Moussavi F, Ocheretyaner E, Sharma R, Brown C, Eilertson B. Carbapenem-resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime-avibactam. Transpl Infect Dis. 2018;20(2):e12837. doi:10.1111/tid.12837
   PubMed Web of Science ®Google Scholar
• De León-Borrás R, Álvarez-cardona J, Vidal JA, Guiot HM. Ceftazidime/Avibactam for refractory bacteremia, vertebral diskitis/osteomyelitis with pre-vertebral abscess and bilateral psoas pyomyositis secondary to Klebsiella pneumoniae Carbapenemase-Producing Bacteria (KPC). P R Health Sci J. 2018;37(2):128–131.
   PubMed Web of Science ®Google Scholar
• Corbella L, Boán J, San-Juan R, et al. Effectiveness of ceftazidime-avibactam for treatment of infections due to Pseudomonas aeruginosa. Int J Antimicrob Agents. 2022;59(2):106517. doi:10.1016/j.ijantimicag.2021.106517
   PubMed Web of Science ®Google Scholar
• Menon KV, Sorour TMM. Epidemiologic and demographic attributes of primary spondylodiscitis in a Middle Eastern population sample. World Neurosurg. 2016;95:31–39. doi:10.1016/j.wneu.2016.07.088
   PubMed Web of Science ®Google Scholar
• Tonziello G, Valentinotti R, Stacul F, Giacomazzi D, Luzzati R. Spinal lesions by infectious spondylodiscitis and hepatocellular carcinoma presenting as spinal metastasis in an HIV-HCV co-infected patient. Infez Med. 2015;23(2):187–191.
   PubMedGoogle Scholar
• Kdous M, Kraiem NE, Zhioua F, Ferchiou M. Pyogenic spondylodiscitis after laparoscopic sacral colpopexy with staples. Gynecol Obstet Fertil. 2015;43(6):478–480. doi:10.1016/j.gyobfe.2015.03.013
   PubMedGoogle Scholar
• Dalwai R, Menon KV, Kumar RJ. Pyogenic diskitis of the L5-S1 disk space following inadvertent placement of a sacrocolpopexy screw. Int J Gynaecol Obstet. 2010;111(3):268–269. doi:10.1016/j.ijgo.2010.07.012
   PubMed Web of Science ®Google Scholar
• Nourbakhsh A, Garges KJ. Spondylodiscitis after vertebral fracture in the thoracic spine. Am J Orthop. 2009;38(10):E166–E169.
   PubMedGoogle Scholar
• Koulaouzidis A, Christie E, Mitchell T, Bhat S. Spontaneous infectious spondylodiscitis (SIS) or pseudo-Pott’s disease. J Pak Med Assoc. 2007;57(9):474.
   PubMedGoogle Scholar
• Gisserot O, Cremades S, Leyral G, Brisou P, de Jaureguiberry JP. Pseudo-Pott’s disease due to Pseudomonas aeruginosa. Presse Med. 2003;32(11):523–524.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Sakuma T, Fukuda Y, Harada J, Tada S. MR imaging of infected spondylodiskitis: interval signal change in vertebral body (including enhanced image of vertebral body). Nihon Igaku Hoshasen Gakkai Zasshi. 1995;55(8):555–561.
   PubMedGoogle Scholar
• Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65(Suppl. 3):11–24. doi:10.1093/jac/dkq303
   Google Scholar
• Mackenzie AR, Laing RBS, Smith CC, Kaar GF, Smith FW. Spinal epidural abscess: the importance of early diagnosis and treatment. J Neurol Neurosurg Psychiatry. 1998;65(2):209–212. doi:10.1136/jnnp.65.2.209
   PubMed Web of Science ®Google Scholar
• Allegranzi B, Tomczky S, Grayson ML, et al. Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter Baumannii and Pseudomonas Aeruginosa in Health Care Facilities. World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Zhang Y, Chen XL, Huang AW, et al. Mortality attributable to carbapenem- resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies. Emerg Microbes Infect. 2016;5(3):e27. doi:10.1038/emi.2016.22
   PubMedGoogle Scholar
• Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program, 1997–1999. Clin Infect Dis. 2001;32(Suppl 2):S146–S155. doi:10.1086/320186
   PubMedGoogle Scholar
• Martins AF, Rosa GS, Saldanha GZ, et al. Epidemiologia dos microrganismos multirresistentes [Epidemiology of multidrug-resistant microorganisms]. In: Martins AF, Barros LS, editors. Prevenção de infecções por microrganismos multirresistentes em serviços de saúde [Prevention of infections by multidrug-resistant microorganisms in health services]. Brasília: Agência Nacional de Vigilância Sanitária; 2021:10–24.
   Google Scholar
• Mchenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis. 2002;34(10):1342–1350. doi:10.1086/340102
   PubMed Web of Science ®Google Scholar
• Park K-H, Cho OH, Jung M, et al. Clinical characteristics and outcomes of hematogenous vertebral osteomyelitis caused by gram-negative bacteria. J Infect. 2014;69(1):42–50. doi:10.1016/j.jinf.2014.02.009
   PubMed Web of Science ®Google Scholar
• Lemaignen A, Ghout I, Dinh A, et al. Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis. Medicine. 2017;96(21):e6387. doi:10.1097/MD.0000000000006387
   PubMed Web of Science ®Google Scholar
• De Graeff JJ, Pereira NRP, Van Wulfftenpalthe OD, Nelson SB, Schwab JH. Prognostic factors for failure of antibiotic treatment in patients with osteomyelitis of the spine. Spine. 2017;42(17):1339–1346. doi:10.1097/MD.0000000000006387
   PubMed Web of Science ®Google Scholar
• Chew FS, Kline MJ. Diagnostic yield of CT-guided percutaneous aspiration procedures in suspected spontaneous infectious diskitis. Radiology. 2001;218(1):211–214. doi:10.1148/radiology.218.1.r01ja06211
   PubMed Web of Science ®Google Scholar
• Falavigna A, Ferraz FAP. Espondilodiscite cervical espontânea causada por Salmonella typhi em paciente imunocompetente [Immunocompetent patient with spontaneous cervical spondylodiscitis caused by Salmonella typhi]. Arq Neuropsiquiatr. 2002;60(4):1034–1037. doi:10.1590/S0004-282X2002000600029
   PubMedGoogle Scholar
• Feki A, Akrout R, Masmoudi K, et al. Infectious spondylodiscitis: a twenty-year experience from a single tertiary referral center. Egypt Rheumatol. 2018;41(3):231–235. doi:10.1016/j.ejr.2018.07.006
   Web of Science ®Google Scholar
• Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF. Antibiotic penetration into bone and joints: an updated review. Int J Infect Dis. 2019;81:128–136. doi:10.1016/j.ijid.2019.02.005
   PubMed Web of Science ®Google Scholar
• Davido B, Crémieux AC, Vaugier I, et al. Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae. Int J Antimicrob Agents. 2023;61(1):106702. doi:10.1016/j.ijantimicag.2022.106702
   PubMed Web of Science ®Google Scholar
• Schimmenti A, Brunetti E, Seminari E, Mariani B, Cambieri P, Orsolini P. Prosthetic joint infection from carbapenemase-resistant Klebsiella pneumoniae successfully treated with ceftazidime-avibactam. Case Rep Infect Dis. 2018;2018:1854805. doi:10.1155/2018/1854805
   PubMed Web of Science ®Google Scholar
• Mittal J, Szymczak WA, Guo Y, et al. Two for the price of one: emerging carbapenemases in a returning traveller to New York City. BMJ Case Rep. 2018;2018:bcr–2018225440. doi:10.1136/bcr-2018-225440
   Google Scholar
• Mularoni A, Mezzatesta ML, Pilato M, et al. Combination of aztreonam, ceftazidime-avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis. Int J Infect Dis. 2021;108:510–512. doi:10.1016/j.ijid.2021.05.085
   PubMed Web of Science ®Google Scholar
• Ji Z, Sun K, Li Z, Cheng W, Yang J. Carbapenem-resistant Klebsiella pneumoniae osteomyelitis treated with ceftazidime-avibactam in an infant: a case report. Infect Drug Resist. 2021;14:3109–3113. doi:10.2147/IDR.S32005
   PubMed Web of Science ®Google Scholar